Newsletter Subject

No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Feb 9, 2024 09:06 PM

Email Preheader Text

Oncology Update Friday, February 09, 2024 ADVERTISEMENT Exclusives & Features PURPOSE: Crenolanib is

[MEDPAGE TODAY]( Oncology Update Friday, February 09, 2024 [No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More]( [Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation]( [Pulled Myeloma Drug May Have a Role in Treating the Disease After All]( [Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib]( [Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Risk]( ADVERTISEMENT Exclusives & Features [Publisher Retracts Three Abortion Studies]( [Small Decline Seen in Ob/Gyn Residency Applications in Abortion Ban States]( [Expensive Generics: Where Direct-to-Consumer Pharmacies Fall Short]( [Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.]( PURPOSE: Crenolanib is a second-generation tyrosine kinase inhibitor with activity against FLT3-ITD- and TKD-mutant AML. We conducted a trial of crenolanib plus intensive chemotherapy in adults with... [READ MORE]( [Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.]( Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or... [READ MORE]( [Where 11 cancer centers stand financially: Moody]( Discover the top cancer centers and hospitals with strong programs, rated in the "A" range by Moody's, a leading provider of credit ratings and risk analysis. [READ MORE]( [Cleveland Clinic study finds unique tumor traits in young colon cancer patients]( "New findings from Cleveland Clinic researchers reveal distinct bacteria in tumors of young-onset colorectal cancer patients, providing insight for targeted scr [READ MORE]( [NCCN publishes 1st set of guidelines on treating solid tumors in pediatric patients]( The first set of guidelines for treating solid tumors in children, published by the National Comprehensive Cancer Network. [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-02-09&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.